Form 4 for RKLB Rocket Lab Corp
Accepted 2022-09-07 00:00:00 ET · period of report 2022-09-02 · accession 0000899243-22-030587 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-07 | 2022-09-02 | RKLB | Frank Edward H. | Dir | A - Grant | $0.00 | +67.6K | 67.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-02 | A | A | 67,589 | $0.00 | 67,589 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted to Dr. Frank under the Company's Amended and Restated Non-Employee Director Compensation Policy. Such RSUs vest as follows: 1/3 of the RSUs will vest September 2, 2023, 1/3 will vest September 2, 2024, and 1/3 will vest September 2, 2025, in each case subject to the reporting person's continuous service relationship through each applicable vesting date. The RSUs were granted on September 2, 2022. |